Brain-sparing radiation for cancer that has spread to the spinal fluid
Part of Brain & nervous system, Cancer, Lungs & breathing, Skin clinical trials.
This trial tests a special type of radiation therapy that aims to treat cancer cells in the spinal fluid while protecting the brain's memory areas. It is for people with breast or lung cancer (or other solid tumors) that has spread to the fluid around the brain and spinal cord.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer that has spread to the fluid around the brain or spinal cord (called leptomeningeal metastases).
- You have breast cancer, non-small cell lung cancer, or another solid tumor cancer.
- You are 18 years or older.
- You are able to care for yourself (score of 60 or higher on the Karnofsky scale).
- You are not pregnant or breastfeeding, and you agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests proton radiation to treat cancer that has spread into the thin lining around the brain and/or spinal cord (leptomeningeal metastasis). It may help control disease in that area while aiming to better protect surrounding healthy tissue.
This trial tests a combination of low-dose radiation to the whole brain, immunotherapy, and chemotherapy given through a lumbar puncture. It is for people with lung cancer that has spread to the lining of the brain and has not responded to standard treatments.
This trial tests a treatment given directly into the fluid around the brain and spinal cord (intrathecal injection) using two drugs—pemetrexed and bevacizumab—for people with non-small cell lung cancer that has spread to that area (leptomeningeal metastases). It may be an option if your current treatment is no longer working.
This trial tests a chemotherapy drug called thiotepa, given through a small device placed under the scalp (Ommaya reservoir) that delivers the drug directly into the spinal fluid. It is for people with non-small cell lung cancer that has spread to the lining of the brain or spinal cord and who have stopped responding to certain targeted therapies.
This trial tests a chemotherapy drug given directly into the spinal fluid for people with HER2-negative breast cancer that has spread to the lining of the brain and spinal cord (called leptomeningeal metastasis). It may help when standard treatments have stopped working or caused too many side effects.
This trial tests whether a precise type of radiation to the brain and spine (craniospinal irradiation) can help control cancer that has spread to the lining of the brain and spinal cord (leptomeningeal disease) in people with breast cancer or non-small cell lung cancer. The goal is to improve symptoms and slow disease progression.
Hear when a new Leptomeningeal Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.